SANUWAVE Health (SNWV) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$44.0M

Revenue (quarter)

$9.7M

Revenue growth (year over year)

−3.13%

Gross profit (trailing twelve months)

$33.6M

Gross margin

76.33%

Net income (trailing twelve months)

$15.3M

Net income (quarter)

−$682,000.00

Net income growth (year over year)

−223.77%

Net margin

34.66%

Return on equity

—

EPS (trailing twelve months)

$1.78

Book value per share

$0.32

P/E (trailing twelve months)

2.90

Price to book

15.87

Debt to assets

92.39%

Payout ratio

—

Dividend yield

—

Company profile

SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.

• Is SANUWAVE Health (SNWV) profitable?

  Yes. SANUWAVE Health earned $15.3M in net income over the trailing twelve months, a net margin of 34.66%.

• How much revenue does SANUWAVE Health (SNWV) make?

  SANUWAVE Health generated $44.0M in revenue over the trailing twelve months, down 3.13% year over year.

• What is SNWV's P/E ratio?

  SANUWAVE Health trades at 2.9 times trailing twelve-month earnings, on an EPS of $1.78.

• How do I buy stock in SANUWAVE Health (SNWV)?

  SNWV trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.